Trial intelligence / Profile preview

BDD and UDCA for Liver Function After Cholecystectomy

NCT03578055Phase 3Unknown

Sponsor
Ewha Womans University Mokdong Hospital
Start
Apr 2018
Primary completion
Nov 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in cholecystitis comparing BDD with UDCA with Placebo (2 arms). Primary endpoints: Serum Aspartate Aminotransferase and Serum Alanine Aminotransferase. Status: unknown.

02

Drugs

bifendateursodeoxycholic acid
03

Conditions

cholecystitis

Beyond the preview

Go deeper on NCT03578055.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03578055.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call